Channel Wealth LLC Cue Biopharma, Inc. Transaction History

Channel Wealth LLC

  • $304 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 24, 2023
SELL
$2.23 - $4.69 $119,082 - $250,446
-53,400 Reduced 77.73%
15,300 $35.2 Million
Q2 2023

Jul 26, 2023
BUY
$3.11 - $4.91 $26,901 - $42,471
8,650 Added 14.4%
68,700 $251 Million
Q1 2023

Apr 27, 2023
BUY
$2.41 - $3.74 $144,720 - $224,587
60,050 New
60,050 $214 Million

Others Institutions Holding CUE

# of Institutions
52
Shares Held
14.1M
Call Options Held
14.4K
Put Options Held
2.6K
View Full List

About Cue Biopharma, Inc.

CUE Quotes by TradingView
  • Ticker CUE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 35,381,700
  • Market Cap $38.2M
  • Description
  • Cue Biopharma, Inc., a clinical-stage biopharmaceutical company, develops biologic drugs for the selective modulation of the human immune system to treat a range of cancers, chronic infectious diseases, and autoimmune disorders. Its lead drug candidate is CUE-101, a fusion protein biologic that is in Phase 1b clinical trial designed to target an...
More about CUE
Track This Portfolio

Track Channel Wealth LLC Portfolio

Follow Channel Wealth LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Channel Wealth LLC, based on Form 13F filings with the SEC.

News

Stay updated on Channel Wealth LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email